<DOC>
	<DOCNO>NCT00716404</DOCNO>
	<brief_summary>This prospective , observational , multi-center study consecutive enrollment . Up 1,000 patient enrol . The objective post-marketing surveillance study collect clinical usage pattern Benephit Infusion Systems . As result , FlowMedica able : 1 . Better understand quantify usage pattern include patient characteristic , adjunctive procedure , infusion agent . 2 . Collect user-interface information overall customer satisfaction . 3 . Monitor post-marketing device performance .</brief_summary>
	<brief_title>Post-Market Observational Study Intra-Renal Drug Delivery</brief_title>
	<detailed_description />
	<mesh_term>Renal Agents</mesh_term>
	<criteria>Exposure one component Benephit Infusion System Ability give write informed consent Inclusion another clinical study may affect usage Benephit system</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2010</verification_date>
	<keyword>FlowMedica</keyword>
	<keyword>Benephit</keyword>
	<keyword>TRT</keyword>
	<keyword>Patients</keyword>
	<keyword>Components</keyword>
	<keyword>Benephit Infusion System</keyword>
	<keyword>Planned</keyword>
	<keyword>To use</keyword>
</DOC>